Orthopediatrics (KIDS) Other financing activities (2016 - 2024)
Orthopediatrics' quarterly Other financing activities came in at $322000.0 in Q4 2024, down 88.26% quarter-over-quarter from $2.7 million in Q3 2024.
Orthopediatrics has reported Other financing activities for 3 years, with the latest figure at $322000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other financing activities changed N/A year-over-year to $322000.0; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (changed 0.0% YoY), and the FY2024 full-year result was $3.4 million, changed N/A from the prior year.
- Other financing activities for Q4 2024 stood at $322000.0, down from $2.7 million in the prior quarter.
- The five-year high for Other financing activities was $2.7 million in Q3 2024, with the low at $322000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 322,000.00 |
| Dec 31, 2024 | 322,000.00 |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Dec 31, 2017 | -250,000.00 |
| Dec 31, 2017 | -250,000.00 |
| Dec 31, 2016 | 267,000.00 |
| Dec 31, 2016 | 267,000.00 |